Impact of the Erigo Machine on Functional Recovery in ICU Patients
- Conditions
- Trauma Patients Requiring Physical Rehabilitation
- Interventions
- Other: Standard Physical TherapyDevice: Erigo Pro
- Registration Number
- NCT02615990
- Lead Sponsor
- Lisa J. Fryman
- Brief Summary
This study will assess the effects of the Erigo applied as part of the early mobilization program in the Trauma ICU at the University of Kentucky. It is our hypothesis, that with the Erigo, critically ill patients will tolerate verticalization and mobilization earlier and safely resulting in improved outcomes measured by increased mobility and strength on ICU discharge, decreased requirements for mechanical ventilation, reduced complication rates and decreased ICU and hospital LOS.
- Detailed Description
The "Erigo" by Hocoma is a combination of tilt table with a robotic stepper device allowing for cyclic leg loading. Erigo now also includes Functional Electrical Stimulation to optimize active neuromuscular stimulation. It allows for protected gradual verticalization and mobilization based on patient tolerance and progress. It has been shown to improve orthostatic tolerance, cerebral blood flow and muscle strength.
Prospective Randomized Controlled Trial will compare two groups. The patients that meet inclusion criteria will be randomized into either the treatment group or a control group. General ICU mobility guidelines consist of scaled activity related to the patients' stability. The control group will get the general ICU mobility treatments and the treatment group will have one mobility treatment replaced with the Erigo treatment.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 2
Admission to Trauma ICU
- Trauma Patients requiring physical therapy (including severe traumatic brain injury or polytrauma without extremity fractures or unstable thoracic or lumbar spine fracture
- Burn patients requiring physical therapy
- GI surgery patients requiring physical therapy
- Necrotizing fasciitis patient requiring physical therapy
Patients with the following conditions:
- Non-weight bearing on lower extremities
- Untreated DVT
- Active hemorrhage
- Leg length >102cm or <72cm
- Weight >135kg
- Systolic BP > 20mmHg sustained for 10min
- Heart rate >20bpm outside goal for more than 20min
- Intracranial pressure (ICP) >20mmHg sustained for 10min if applicable,
- Temperature >38.2C
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Standard Physical Therapy Standard Physical Therapy Patients will have 3 standard Physcial Therapy session. Patients will have 2 additional PT therapies 20 minutes of standard range of motion movements. Erigo Pro plus standard Physical Therapy Erigo Pro The Erigo device therapy is a combination of tilt table with robotic stepper device allowing for cyclic leg loading. It also includes Functional Electrical Stimulation to optimize active neuromuscular stimulation. It will be used once a day to replace one of the standard PT therapies. The exercise mimics walking beyond what regular range of motion provides. Patients will have 2 additional PT therapies 20 minutes of standard range of motion movements.
- Primary Outcome Measures
Name Time Method Orthostatic Tolerance During Verticalization Up to one year Rapid decreases in blood pressure are a common clinical challenge when trauma patients go from lying down to standing. Changes in blood pressure will be compared between groups to determine if verticalization with an ERIGO Pro tilt table will alleviate the drop in blood pressure more quickly than standard of care. Participants will have their blood pressure measured upon initial verticalization after injury and at each treatment session there after until they achieve ambulation (the ability to move without assistance). Data will be presented as the number of days of treatment required to achieve blood pressure homeostasis during the positional change from lying to standing.
Orthostatic Tolerance During Ambulation Up to one year Rapid decreases in blood pressure are a common clinical challenge when trauma patients go from standing to full ambulation. Changes in blood pressure will be compared between groups to determine if verticalization with an ERIGO Pro tilt table will alleviate the drop in blood pressure more quickly than standard of care. Participants will have their blood pressure measured upon initial unassisted standing and then during each treatment session there after until discharge. Data will be presented as the number of days of treatment required to achieve blood pressure homeostasis during the positional change from standing to full ambulation.
- Secondary Outcome Measures
Name Time Method ICU Length of Stay Up to three months The duration of stay in the Trauma ICU will be measured and compared between groups. Data will be presented as mean number of days in the ICU.
Hospital Length of Stay Up to one year The duration of hospitalization will be measured and compared between groups. Data will be presented as mean number of days the participant is hospitalized.
Incidence of Pneumonia While Hospitalized Up to one year Incidence of pneumonia while hospitalized will be determined by clinical symptoms to include temperature \>100.8 degrees F, WBC\>12,000 WBC/mm3 , PaO2/Fio2 ratio \< 300 mmHg, positive respiratory culture for organisms and chest x-ray indicative of pneumonia. Total incidence will be compared between groups and presented as a total count of pneumonia diagnoses per group.
Incidence of Pressure Ulcers Up to one year Incidence of pressure ulcers determined by physical observation. Total incidence will be compared between groups and presented as a total count of pressure ulcer diagnoses per group.
Incidence of Physical Instability Up to one year Incidence of physical instability with be calculated as the number of falls per participant while hospitalized. Data will be presented as the number of falls per participant per group.
Incidence of Catheter Disruption Up to one year Incidence of unplanned removal/displacement of lines/tubes/catheters. Data will be presented as the number of disruptions per participant per group.
Measure of Physical Capacity At discharge (up to 1 year) Kansas University Hospital Physical Therapy Acute Care Functional Outcome Tool will be utilized to assess the participant's overall physical function prior to discharge. . Total score: 0 - 32, usually divided by 25%, 50%, \>75% (minimum, moderate, maximum functionality). The higher the score, the great physical function the participant has.
Incidence of Deep Vein Thrombosis (DVT) Up to one year Incidence of DVT with be determined based on clinical symptoms to include pain and positive duplex ultrasound or other diagnostic tool
Incidence of Urinary Tract Infections While Hospitalized Up to one year Incidence of urinary tract infection during hospitalization will be determined by clinical symptoms to include temperature of \> 100.8 degrees F, WBC\> 12000 WBC/MM3, patient complaints of pain, positive urine culture. Total incidence will be compared between groups and presented as a total count of urinary tract infection diagnoses per group.
Measure of Muscle Power Up to one year The Muscle Research Council Muscle Scale will be used to determine actual muscle power generation vs the anticipated power generation prior to discharge. Total score: 0 - 5, 5 is normal muscle function. Data are presented as units on a scale.
Fall Risk Up to one year Participant fall risk will be determined prior to discharge using the Berg Balance Scale to assess impairment of balance function through the completion of several functional tasks. The data are presented as units on a scale. The higher the number the lower the fall risk.
Assessment of Participant Mobility Up to one year The ICU Mobility Scale ranks a participant's mobility on a scale of 0-32, were a score of zero is a completely non-mobile individual and a score of 32 is a fully ambulatory individual. Data will be collected at the time of discharge. The data are presented as units on a scale.
Independent Ambulation Up to one year The number of hospital days required for the participant to regain independent ambulation (the ability to walk 5 meters unassisted) with be measured and presented as total days.
Mid-leg Muscle Circumference Up to one year Mid-leg muscle circumference will be measure using a metric tape measure at hospital admission and again just prior to discharge. Data will be presented as the change in muscle circumference (cm) over time.
Number of Patients Discharged From Hospital to Home Up to one year The number of participants discharged to their home will be counted and presented as a percentage of the total participants in that arm.
Number of Patients Discharged From Hospital to Skilled Nursing Facility Up to one year The number of participants discharged to a skilled nursing home will be counted and presented as a percentage of the total participants in that arm.
Number of Patients Discharged From Hospital to a Long Term Care Facility Up to one year The number of participants discharged to a long term care facility will be counted and presented as a percentage of the total participants in that arm.
Number of Patients Discharged From Hospital to an Acute Rehabilitation Facility Up to one year The number of participants discharged to am acute rehabilitation facility will be counted and presented as a percentage of the total participants in that arm.
Trial Locations
- Locations (1)
University of Kentucky
🇺🇸Lexington, Kentucky, United States